Veterinary Medicines

Tricaine Pharmaq 1000 mg/g Powder for Solution for Fish Treatment

Authorised
  • Tricaine mesilate
Download as PDF

Product identification

Medicine name:
Tricaine Pharmaq 1000 mg/g Powder for Solution for Fish Treatment
Tricaine Pharmaq 1000 mg/g Powder for Solution for Fish Treatment
Active substance:
  • Tricaine mesilate
Target species:
  • Ornamental fish
  • Other fish
Route of administration:
  • Dipping

Product details

Active substance and strength:
  • Tricaine mesilate
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for solution for fish treatment
Withdrawal period by route of administration:
  • Dipping
    • Ornamental fish
      • Fish meat
        70
        degree day
    • Other fish
      • Fish meat
        70
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 1000 g.
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 250 g.
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 100 g.
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 25 g.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmaq AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmaq Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10804/006/001
Date of authorisation status change:
Reference member state:
  • Norway
Procedure number:
  • NO/V/0012/001
Concerned member states:
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."